| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.062 | 0.3 |